| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |